Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin
Phase 3
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- NCT00213122
- Lead Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Brief Summary
In this study, the effect of miglitol on daily plasma glucose will be evaluated in type 2 diabetic patients treated with insulin.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- type2 diabetes
- postprandial plasma glucose levels ≧180mg/dl
Read More
Exclusion Criteria
- type1 diabetes
- AST(GOT) or ALT(GPT) ≧100IU/l
- creatinine ≧2.0mg/dl
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method